EuroAPI : Principes actifs pharmaceutiquesWatch our manifesto
Reinventing active ingredient solutions to sustainably meet clients’ and patients’ needs around the world.
With approximately €1 billion in expected sales in 2022, EUROAPI will rank #1 in small molecules APIs, and our strong innovation and R&D capabilities allow us to accelerate our development in more complex molecule segments through CDMO activities.
At approximately 200 APIs, EUROAPI offers one of the largest portfolios in the industry, addressing a wide variety of patients and providing coverage for more than 80 countries.
We provide expertise in Quality, Regulatory and Supply and have dedicated commercial teams for our clients around the globe.
Expert tailor-made partnerships for innovative companies
Approximately 200 APIs available for human & animal health
A global industrial network at your service
We are driven by the success of our clients and their satisfaction
Who We Are, What We Do
Contract Development Manufacturing Organization team
Our Commercial Network is covering 80 cOuntries and our 6 industrial sites are located in Europe
Quality and regulatory cOmpliance
GMP & GDP compliance.
High quality level throughout the manufacturing chain including raw material sourcing.
Strong track record with health authorities.